Related Experiment Videos
Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis
Olivier Michielin1, Martin Karplus
1Ludwig Institute for Cancer Research, Lausanne Branch, Chemin des Boveresses, 155 1066, Epalinges, Switzerland.
Journal of Molecular Biology
|November 26, 2002
Summary
T-cell receptor (TCR) recognition of peptides bound to MHC molecules is crucial for immune responses. Free energy simulations revealed that improved solvation of a mutant peptide enhances TCR binding affinity, aiding cancer immunotherapy design.
Area of Science:
- Immunology
- Computational Biology
- Structural Biology
Background:
- T-cell receptor (TCR) recognition of peptide-MHC complexes is central to adaptive immunity.
- Understanding TCR selectivity is key for developing targeted immunotherapies, including cancer vaccines.
Purpose of the Study:
- To investigate the molecular basis of TCR selectivity using computational methods.
- To analyze the binding free energy difference between a specific TCR (A6) and wild-type (Tax) versus mutant (Tax P6A) peptides presented by HLA A2.
Main Methods:
- Utilized free energy simulation methods to compute binding free energy differences.
- Performed free energy component analysis to dissect contributions to binding affinity.
- Identified key TCR residues involved in peptide recognition.
Main Results:
- Computed a binding free energy difference of 2.9 kcal/mol, aligning with experimental data.
- Identified enhanced solvation of the mutant peptide as a significant factor for increased TCR affinity.
- Pinpointed specific TCR residues critical for selectivity.
Conclusions:
- Free energy simulations provide molecular insights into TCR-peptide-MHC interactions.
- Improved peptide solvation can enhance TCR binding, offering a strategy for designing immunotherapies.
- This approach aids in understanding molecular recognition principles for therapeutic applications.